SEOUL, South Korea, Nov. 25, 2024 /PRNewswire/ -- The latest progress in the clinical trial of BH3120, an innovative immunotherapy jointly developed by Hanmi Pharmaceutical and Beijing Hanmi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback